Extracorporeal treatment of cast nephropathy.

abstract：:The role of peritoneal dialysis (PD) as a modality in renal replacement therapy has been well established. In this article we review various aspects in the evolution of PD, with special emphasis on adequacy. Until the late 1950s PD was still considered as a last resort in the treatment of terminal uremia. The introduc...

journal_title：Seminars in dialysis

authors： Haq NU,Nolph KD

更新日期：2001-07-01 00:00:00

abstract：:Secondary hyperparathyroidism almost universally accompanies end-stage renal disease (ESRD). In some, but not all studies, elevated serum parathyroid hormone (PTH) concentrations are associated with increased fracture rates, cardiovascular disease, and mortality in ESRD. The serum concentration of PTH required for opt...

journal_title：Seminars in dialysis

authors： Zand L,Kumar R

更新日期：2016-05-01 00:00:00

abstract：:Peritoneal dialysis (PD) is an underutilized form of renal replacement therapy. Recent data have emphasized that only 12% of end-stage renal disease (ESRD) patients are initiated on this form of therapy in the United States. Patients requiring PD have most often been referred to general surgeons for catheter placement...

journal_title：Seminars in dialysis

authors： Asif A,Byers P,Gadalean F,Roth D

更新日期：2003-05-01 00:00:00

abstract：:Tunneled dialysis catheters (TDC) become dysfunctional because of placement problems, infection, thrombosis, and fibrin sheath formation. Occasional patients who are catheter dependant develop frequent catheter dysfunction because of thrombosis or thrombosis associated with fibrin sheath formation. This article attemp...

journal_title：Seminars in dialysis

authors： Rasmussen RL

更新日期：2010-11-01 00:00:00

abstract：:Recent experimental and clinical studies suggest the possible utility of niacin (nicotinic acid, vitamin B3) and its metabolite nicotinamide as a means of lowering phosphate levels in dialysis patients via direct inhibition of the Na-Pi-2b sodium-dependent phosphate co-transporter in the GI tract. While the possibilit...

journal_title：Seminars in dialysis

authors： Berns JS

更新日期：2008-05-01 00:00:00

abstract：:Patients with end-stage renal disease are more likely to suffer from gastrointestinal (GI) problems, including bleeding from upper and lower sources. Peptic ulcer disease is the most common cause of upper GI bleeding, and although there is some debate in the literature regarding whether the frequency of ulcer disease ...

journal_title：Seminars in dialysis

authors： Kalman RS,Pedrosa MC

更新日期：2015-01-01 00:00:00

abstract：:The aim of this study was to describe the range and extent of current procedural practices of Nephrologists and trainees in Australia and New Zealand with a specific focus on renal biopsy. A web-based survey was constructed based on a 2009 pilot survey conducted by the authors. The survey was distributed by email. A t...

journal_title：Seminars in dialysis

authors： Ritchie AG,Saunders J,Baer R,May S,Australian and New Zealand Special Interest Group in Interventional Nephrology Research Collaboration.

更新日期：2013-11-01 00:00:00

abstract：:Over the last 10 years an increasing number of patients worldwide have started dialysis or had transplantation. Many are elderly with complex comorbid conditions. Registries across the world all show a rapid and dramatic increase in the number of older patients accepted for renal replacement therapy. In addition, the ...

journal_title：Seminars in dialysis

authors： Krishnan M,Lok CE,Jassal SV

更新日期：2002-03-01 00:00:00

abstract：:Withholding and withdrawal of dialysis has been a reality since dialysis was invented. Only in the past 20 years has it been formally studied, and we still have a great deal to learn. The nephrology community has slowly come to accept that, for some of our patients, not having dialysis is a better option than continui...

journal_title：Seminars in dialysis

authors： Germain MJ,Cohen LM,Davison SN

更新日期：2007-05-01 00:00:00

abstract：:The bone disease associated with end-stage renal failure (ESRD) and treatment are complex and multifactorial, and has changed in both clinical and imaging features over the past three decades. Whereas previously features of vitamin D deficiency (rickets/osteomalacia) and intense, and prolonged, secondary hyperparathyr...

journal_title：Seminars in dialysis

authors： Adams JE

更新日期：2002-07-01 00:00:00

abstract：:There are studies reporting that soluble kltho (sKlotho) deficiency plays a role in cardiovascular disease in addition to traditional risk factors such as diabetes, hypertension, anemia, smoking, and excessive volume burden. Our aim in this study was to investigate the relationship of sKlotho with uremic cardiomyopath...

journal_title：Seminars in dialysis

authors： Erkus E,Buyukterzı Z,Karakose S,Kurku H,Kurtgoz PO,Topal M,Guney I

更新日期：2020-11-30 00:00:00

abstract：:Cardiovascular morbidity and mortality remain frustratingly common in dialysis patients. A dearth of established evidence-based treatment calls for alternative therapeutic avenues to be embraced. Sympathetic hyperactivity, predominantly due to afferent nerve signaling from the diseased native kidneys, has been establi...

journal_title：Seminars in dialysis

authors： Hoye NA,Wilson LC,Jardine DL,Walker RJ

更新日期：2019-05-01 00:00:00

abstract：:The elderly people, 65 years old and above, are growing in number. The structural and functional changes associated with aging place the elderly at risk when challenged by extracorporeal therapies, such as therapeutic plasma exchange (TPE). We retrospectively analyzed data on all patients who underwent TPE for renal i...

journal_title：Seminars in dialysis

authors： Hayes JS,Balogun RA,Chang J,Abdel-Rahman EM

更新日期：2012-03-01 00:00:00

abstract：:Late referral of patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) for evaluation of kidney transplantation is common. Even though renal transplantation offers a clear survival benefit to patients with advanced CKD and ESRD and should be considered the renal replacement therapy of choice, n...

journal_title：Seminars in dialysis

authors： Peev V

更新日期：2016-07-01 00:00:00

abstract：:Pulmonary hypertension (PH) is a progressive, fatal pulmonary circulatory disease that accompanies many conditions (including left to right side shunt) with compensatory elevated cardiac output. PH also complicates chronic hemodialysis (HD) therapy immediately after the creation of an arteriovenous (AV) access, even b...

journal_title：Seminars in dialysis

authors： Yigla M,Abassi Z,Reisner SA,Nakhoul F

更新日期：2006-09-01 00:00:00

abstract：:In patients receiving hemodialysis, the provision of safe and effective vascular access using an arteriovenous fistula or graft is regarded as a critical priority by patients and health professionals. Vascular access failure is associated with morbidity and mortality, such that strategies to prevent these outcomes are...

journal_title：Seminars in dialysis

authors： Viecelli AK,Mori TA,Roy-Chaudhury P,Polkinghorne KR,Hawley CM,Johnson DW,Pascoe EM,Irish AB

更新日期：2018-05-01 00:00:00

abstract：:Both the morbidity of the uremic syndrome and the generation of uremic toxins are attributed to malnutrition. If protein intake and catabolism result in the generation of solutes, then nutritional intake should be related directly to toxicity. On the other hand, inadequate nutrition has been linked to inflammation and...

journal_title：Seminars in dialysis

authors： Vanholder R,Glorieux G,Lameire N

更新日期：2002-09-01 00:00:00

abstract：:This review aims to summarize the available evidence of the effectiveness of oral iron in patients receiving dialysis. Four small randomized controlled trials (105 evaluated patients) compared oral iron supplements with placebo or no treatment; hemoglobin and ferritin levels did not differ significantly between groups...

journal_title：Seminars in dialysis

authors： Hodson EM,Craig JC

更新日期：2014-01-01 00:00:00

abstract：:The majority of end-stage renal disease (ESRD) patients are hypertensive. Drug therapy for hypertension in hemodialysis (HD) patients includes all classes of antihypertensive drugs, with the sole exception of diuretics. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers may decrease mo...

journal_title：Seminars in dialysis

authors： Hörl MP,Hörl WH

更新日期：2004-07-01 00:00:00

abstract：:Iodinated contrast agents are well tolerated in ESRD patients. Certain types of ICM, i.e., LOCM and the nonionic agents are associated with better safety profiles. Current available evidence, although not optimal, does not support the need for additional hemodialysis for ICM removal to preserve residual renal function...

journal_title：Seminars in dialysis

authors： Khan SF,Kalantari K

更新日期：2014-11-01 00:00:00

abstract：:Intravenous iron is an important component of the treatment of anemia of end-stage renal disease (ESRD), but it is biologically plausible that iron could increase the risk of infection through impairment of neutrophil and T-cell function and promotion of microbial growth. Any such increase in risk would be particularl...

journal_title：Seminars in dialysis

authors： Ishida JH,Johansen KL

更新日期：2014-01-01 00:00:00

abstract：:Dialysis is measured as Kt/V, which scales the dose (Kt) to body water content (V). Scaling dialysis dose to body surface area (S(dub)) has been advocated, but the implications of such rescaling have not been examined. We developed a method of rescaling measured Kt/V to S(dub) and studied the effect of such alternativ...

journal_title：Seminars in dialysis

authors： Daugirdas JT,Depner TA,Greene T,Kuhlmann MK,Levin NW,Chertow GM,Rocco MV

更新日期：2008-09-01 00:00:00

abstract：:Hepatitis C virus (HCV) infection is not only an important cause of chronic liver disease, but extrahepatic manifestations are common and include chronic kidney disease (CKD). HCV is classically associated with cryoglobulinemic glomerulonephritis in the context of mixed cryoglobulinemia syndrome, but other glomerular ...

journal_title：Seminars in dialysis

authors： Henson JB,Sise ME

更新日期：2019-03-01 00:00:00

abstract：:Dysfunction of arteriovenous fistulas (AVF) and arteriovenous grafts (AVG) contribute significantly to morbidity and hospitalization in the dialysis population. Despite advances in endovascular techniques, the incidence of vascular access stenosis remains problematic. Currently, the role of endovascular stent placemen...

journal_title：Seminars in dialysis

authors： Fu N,Joachim E,Yevzlin AS,Shin JI,Astor BC,Chan MR

更新日期：2015-05-01 00:00:00

abstract：:Analysis of tissues, plasma, urine, other body fluids, and dialysate for glycation adducts has revealed the presence of two major forms: glycation adduct residues of proteins and related glycated amino acids--called glycation free adducts. The major effect on protein glycation in uremia is loss of clearance of glycati...

journal_title：Seminars in dialysis

authors： Thornalley PJ,Rabbani N

更新日期：2009-07-01 00:00:00

abstract：:Automated peritoneal dialysis (APD) has experienced significant growth in highly developed nations in the last few years, while in developing countries with important social, educational, and financial constraints this treatment modality is, at best, trying to emerge. APD offers advantages that make it popular. Some o...

journal_title：Seminars in dialysis

authors： Correa-Rotter R

更新日期：2002-11-01 00:00:00

abstract：:Dialysis patients are at high risk for fracture, with published rates in excess of a 20% probability of fracture over the next 10 years of dialysis. Unfortunately, there is no accepted methodology for quantifying this risk in advance of the first fracture; conventional bone densitometry performs unreliably in this rol...

journal_title：Seminars in dialysis

authors： Jamal SA,Hodsman AB

更新日期：2011-01-01 00:00:00

abstract：:Patients undergoing chronic renal replacement therapy have a high incidence of dyslipidemia. In general, there are increased concentrations of triglyceride-rich apolipoprotein B-containing particles. These elevations lead to increased levels of non-high-density lipoprotein (HDL) levels. This pattern is further modifie...

journal_title：Seminars in dialysis

authors： Liu J,Rosner MH

更新日期：2006-01-01 00:00:00

abstract：:Calcific uremic arteriolopathy (CUA) is a rare but serious life-threatening complication of CRF that manifests as painful nonhealing eschars in association with panniculitis and dermal necrosis. This condition is being increasingly recognized and reported as a contributing factor to death in dialysis patients. The pat...

journal_title：Seminars in dialysis

authors： Rogers NM,Teubner DJ,Coates PT

更新日期：2007-03-01 00:00:00

abstract：:Growing evidence has been gathered over the last 15 years regarding the role of nontraditional or uremia-related risk factors in the pathogenesis of atherosclerosis in subjects with renal failure. Among those factors, dyslipidemia, inflammation, hyperhomocysteinemia, and oxidant stress have been extensively studied. H...

journal_title：Seminars in dialysis

authors： Madore F

更新日期：2003-03-01 00:00:00